Catalent Inhalation Capabilities

For over 30 years, Catalent has helped customers with their development and commercialization of inhalation products. Learn about the capabilities of Catalent's inhalation network, supporting the development and manufacture of formulations delivered by Dry Powder Inhalers (DPIs) and unit- or bi-dose nasal sprays.

Catalent Solutions for Inhaled Medicines

Catalent's operation integrates its knowledge and experience in pre-formulation sciences, formulation development, device evaluation/ selection, CMC, manufacturing, and product characterization to reliably deliver therapies across all common inhalation dosage forms including Dry Powder Inhalers (DPIs) and nasal sprays.

Dry Powder Inhalers (DPIs)

Catalent offers best-in-class commercial-scale powder and capsule manufacture for Dry Powder Inhalers (DPIs). With a top-tier vendor set, the largest-scale CGMP pharmaceutical spray dryer in North America and an established track record of commercial launch and manufacturing expertise, Catalent is well-equipped to handle a wide variety of tech transfer and scale-up projects.

Unit and Bi-Dose Nasal Sprays

Catalent offers end-to-end services that can help expedite your nasal spray product from concept to market including dosage form selection, formulation development, analytical testing, and clinical to commercial scale manufacturing. From early development through commercialization, Catalent offers comprehensive inhalation solutions to help get your products to market faster.

Inhalation Development & Analytical Services

Catalent leverages decades of experience in the development and evaluation of inhalation products to provide turn-key solutions, focused on driving effective regulatory submissions. As a leader in the development and characterization of inhalation products, Catalent offers analytical support services throughout your product's lifecycle.